Products: surgical-robot, neuro-robot. Risk band: Elevated
RobotRisk index 21.0/100 (severity- and time-weighted incidents) · ranked 16 of 25 among Medical robotics companies with incidents (173 tracked).
Analyst brief
Accuray's record in the medical-robotics category spans three FDA Class II recalls from 2013 to 2021, covering the RoboCouch Patient Positioning System, the CyberKnife Robotic Radiosurgery System (models G3, G4, VSI), and the CyberKnife Treatment Delivery System. All three entries carry a uniform severity rating of 3, and all are classified identically as recalls, showing a consistent failure mode centered on device-level product corrections rather than escalating severity over time. Accuray's index of 21.1 ranks 16 of 25 companies in Medical robotics with incident history. The record is regulator-driven, consisting entirely of FDA recall classifications spanning an eight-year interval rather than a clustered or press-originated pattern.
Risk index
21.0/100RobotRisk index
22.1/100Median index across the 25 Medical robotics companies with incident history (173 tracked, 148 with none)
16 of 25Rank in Medical robotics (of 25 with incident history)